Larimar Therapeutics Inc. buy Quitte
Start price
04.10.16
/
50%
€37.88
Target price
31.01.17
€44.38
Performance (%)
17.14%
End price
31.01.17
€44.38
Summary
This prediction ended on 31.01.17 with a price of €44.38. The prediction had a final performance of 17.14%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Larimar Therapeutics Inc. | 27.517% | 27.517% | 234.507% | 17.284% |
iShares Core DAX® | 1.776% | 3.175% | 14.882% | 17.660% |
iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% | 52.324% |
iShares Nikkei 225® | -0.335% | 3.857% | 14.485% | 11.459% |
iShares S&P 500 | 0.854% | 2.567% | 31.105% | 47.441% |
Comments by Quitte for this prediction
In the thread Zafgen Inc. diskutieren
Macht Anstalten, den Boden zu verlassen
Quitte stimmt am 04.10.2016 dem Buy-Gesamtsentiment mit dem Kursziel 4.5$ zu.
(Zielkurs erreicht)